Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-004064
Filing Date
2025-02-05
Accepted
2025-02-05 16:31:45
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738791099.html 4  
1 FORM 4 wk-form4_1738791099.xml 4 3798
  Complete submission text file 0001628280-25-004064.txt   5247
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807
Business Address
Patel Gautam (Reporting) CIK: 0001738054 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 25593804